Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash to Debt 0.19
WOOF's Cash to Debt is ranked higher than
69% of the 302 Companies
in the Global Medical Care industry.

( Industry Median: 0.19 vs. WOOF: 0.19 )
WOOF' s 10-Year Cash to Debt Range
Min: 0.02   Max: No Debt
Current: 0.19

Equity to Asset 0.57
WOOF's Equity to Asset is ranked higher than
84% of the 303 Companies
in the Global Medical Care industry.

( Industry Median: 0.41 vs. WOOF: 0.57 )
WOOF' s 10-Year Equity to Asset Range
Min: 0.1   Max: 0.65
Current: 0.57

0.1
0.65
Interest Coverage 13.16
WOOF's Interest Coverage is ranked higher than
82% of the 194 Companies
in the Global Medical Care industry.

( Industry Median: 5.06 vs. WOOF: 13.16 )
WOOF' s 10-Year Interest Coverage Range
Min: 0.64   Max: 9999.99
Current: 13.16

0.64
9999.99
F-Score: 8
Z-Score: 4.27
M-Score: -2.69
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 12.84
WOOF's Operating margin (%) is ranked higher than
85% of the 305 Companies
in the Global Medical Care industry.

( Industry Median: 8.59 vs. WOOF: 12.84 )
WOOF' s 10-Year Operating margin (%) Range
Min: 5   Max: 20.62
Current: 12.84

5
20.62
Net-margin (%) 7.03
WOOF's Net-margin (%) is ranked higher than
83% of the 305 Companies
in the Global Medical Care industry.

( Industry Median: 4.91 vs. WOOF: 7.03 )
WOOF' s 10-Year Net-margin (%) Range
Min: -8.05   Max: 10.73
Current: 7.03

-8.05
10.73
ROE (%) 10.03
WOOF's ROE (%) is ranked higher than
75% of the 286 Companies
in the Global Medical Care industry.

( Industry Median: 9.56 vs. WOOF: 10.03 )
WOOF' s 10-Year ROE (%) Range
Min: -18.41   Max: 40.53
Current: 10.03

-18.41
40.53
ROA (%) 5.86
WOOF's ROA (%) is ranked higher than
82% of the 306 Companies
in the Global Medical Care industry.

( Industry Median: 3.52 vs. WOOF: 5.86 )
WOOF' s 10-Year ROA (%) Range
Min: -5.89   Max: 11.29
Current: 5.86

-5.89
11.29
ROC (Joel Greenblatt) (%) 51.88
WOOF's ROC (Joel Greenblatt) (%) is ranked higher than
89% of the 305 Companies
in the Global Medical Care industry.

( Industry Median: 18.24 vs. WOOF: 51.88 )
WOOF' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 21.82   Max: 116.68
Current: 51.88

21.82
116.68
Revenue Growth (%) 8.20
WOOF's Revenue Growth (%) is ranked higher than
79% of the 239 Companies
in the Global Medical Care industry.

( Industry Median: 6.10 vs. WOOF: 8.20 )
WOOF' s 10-Year Revenue Growth (%) Range
Min: 0   Max: 127.2
Current: 8.2

0
127.2
EBITDA Growth (%) 7.90
WOOF's EBITDA Growth (%) is ranked higher than
80% of the 191 Companies
in the Global Medical Care industry.

( Industry Median: 6.50 vs. WOOF: 7.90 )
WOOF' s 10-Year EBITDA Growth (%) Range
Min: 0   Max: 227.9
Current: 7.9

0
227.9
EPS Growth (%) 6.40
WOOF's EPS Growth (%) is ranked higher than
72% of the 184 Companies
in the Global Medical Care industry.

( Industry Median: 10.90 vs. WOOF: 6.40 )
WOOF' s 10-Year EPS Growth (%) Range
Min: 0   Max: 110.5
Current: 6.4

0
110.5
» WOOF's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q4 2013

WOOF Guru Trades in Q4 2013

Third Avenue Management 636,712 sh (New)
Paul Tudor Jones 24,494 sh (New)
Jim Simons 2,032,700 sh (+207.52%)
Ray Dalio 28,400 sh (+20.34%)
Richard Pzena 1,065,569 sh (+0.41%)
Ron Baron 200,000 sh (unchged)
Chuck Royce 230,087 sh (-12.78%)
Joel Greenblatt 112,594 sh (-33.97%)
Steven Cohen 11,072 sh (-63.29%)
» More
Q1 2014

WOOF Guru Trades in Q1 2014

Larry Robbins 1,537,859 sh (New)
Louis Moore Bacon 150,000 sh (New)
Steven Cohen 43,202 sh (+290.19%)
Joel Greenblatt 117,629 sh (+4.47%)
Third Avenue Management 636,712 sh (unchged)
Ron Baron 200,000 sh (unchged)
Paul Tudor Jones Sold Out
Ray Dalio Sold Out
Jim Simons 1,920,800 sh (-5.5%)
Richard Pzena 764,519 sh (-28.25%)
Chuck Royce 23,200 sh (-89.92%)
» More
Q2 2014

WOOF Guru Trades in Q2 2014

Ray Dalio 5,924 sh (New)
Larry Robbins 8,791,170 sh (+471.65%)
Joel Greenblatt 394,112 sh (+235.05%)
Ron Baron 200,000 sh (unchged)
Louis Moore Bacon Sold Out
Chuck Royce Sold Out
Jim Simons 1,794,100 sh (-6.6%)
Third Avenue Management 557,312 sh (-12.47%)
Richard Pzena 312,197 sh (-59.16%)
» More
Q3 2014

WOOF Guru Trades in Q3 2014

Richard Pzena Sold Out
Ray Dalio Sold Out
Larry Robbins 8,686,170 sh (-1.19%)
Jim Simons 1,464,600 sh (-18.37%)
Third Avenue Management 447,732 sh (-19.66%)
Joel Greenblatt 149,850 sh (-61.98%)
Ron Baron 50,000 sh (-75%)
» More
» Details

Insider Trades

Latest Guru Trades with WOOF

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Joel Greenblatt 2014-09-30 Reduce -61.98%0.11%$35.41 - $41.82 $ 46.9221%149850
Richard Pzena 2014-09-30 Sold Out 0.06%$35.41 - $41.82 $ 46.9221%0
Ron Baron 2014-09-30 Reduce -75%0.02%$35.41 - $41.82 $ 46.9221%50000
Ray Dalio 2014-09-30 Sold Out $35.41 - $41.82 $ 46.9221%0
Joel Greenblatt 2014-06-30 Add 235.05%0.12%$29.58 - $36.11 $ 46.9244%394112
Richard Pzena 2014-06-30 Reduce -59.16%0.08%$29.58 - $36.11 $ 46.9244%312197
Ray Dalio 2014-06-30 New Buy$29.58 - $36.11 $ 46.9244%5924
Richard Pzena 2014-03-31 Reduce -28.25%0.06%$30.45 - $34.85 $ 46.9245%764519
Ray Dalio 2014-03-31 Sold Out 0.01%$30.45 - $34.85 $ 46.9246%0
Third Avenue Management 2013-12-31 New Buy0.37%$27.07 - $31.44 $ 46.9261%636712
Joel Greenblatt 2013-12-31 Reduce -33.97%0.05%$27.07 - $31.44 $ 46.9261%112594
Ray Dalio 2013-12-31 Add 20.34%$27.07 - $31.44 $ 46.9261%28400
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 31.80
WOOF's P/E(ttm) is ranked higher than
78% of the 326 Companies
in the Global Medical Care industry.

( Industry Median: 43.60 vs. WOOF: 31.80 )
WOOF' s 10-Year P/E(ttm) Range
Min: 10.27   Max: 56.67
Current: 31.8

10.27
56.67
P/B 3.15
WOOF's P/B is ranked higher than
71% of the 326 Companies
in the Global Medical Care industry.

( Industry Median: 2.96 vs. WOOF: 3.15 )
WOOF' s 10-Year P/B Range
Min: 1.23   Max: 9.87
Current: 3.15

1.23
9.87
P/S 2.23
WOOF's P/S is ranked higher than
64% of the 326 Companies
in the Global Medical Care industry.

( Industry Median: 1.55 vs. WOOF: 2.23 )
WOOF' s 10-Year P/S Range
Min: 0.94   Max: 3.42
Current: 2.23

0.94
3.42
PFCF 21.62
WOOF's PFCF is ranked higher than
86% of the 326 Companies
in the Global Medical Care industry.

( Industry Median: 85.90 vs. WOOF: 21.62 )
WOOF' s 10-Year PFCF Range
Min: 10.66   Max: 36.75
Current: 21.62

10.66
36.75
EV-to-EBIT 18.69
WOOF's EV-to-EBIT is ranked higher than
79% of the 326 Companies
in the Global Medical Care industry.

( Industry Median: 22.71 vs. WOOF: 18.69 )
WOOF' s 10-Year EV-to-EBIT Range
Min: 7.3   Max: 29.7
Current: 18.69

7.3
29.7
Shiller P/E 35.78
WOOF's Shiller P/E is ranked higher than
84% of the 326 Companies
in the Global Medical Care industry.

( Industry Median: 1193.86 vs. WOOF: 35.78 )
WOOF' s 10-Year Shiller P/E Range
Min: 10.58   Max: 51.63
Current: 35.78

10.58
51.63
Current Ratio 1.60
WOOF's Current Ratio is ranked higher than
80% of the 306 Companies
in the Global Medical Care industry.

( Industry Median: 1.34 vs. WOOF: 1.60 )
WOOF' s 10-Year Current Ratio Range
Min: 0.53   Max: 5.59
Current: 1.6

0.53
5.59
Quick Ratio 1.33
WOOF's Quick Ratio is ranked higher than
76% of the 306 Companies
in the Global Medical Care industry.

( Industry Median: 1.21 vs. WOOF: 1.33 )
WOOF' s 10-Year Quick Ratio Range
Min: 0.47   Max: 5.41
Current: 1.33

0.47
5.41

Valuation & Return

vs
industry
vs
history
Price/DCF (Projected) 1.59
WOOF's Price/DCF (Projected) is ranked higher than
83% of the 326 Companies
in the Global Medical Care industry.

( Industry Median: 4.19 vs. WOOF: 1.59 )
WOOF' s 10-Year Price/DCF (Projected) Range
Min: 0.63   Max: 9
Current: 1.59

0.63
9
Price/Median PS Value 1.27
WOOF's Price/Median PS Value is ranked higher than
71% of the 326 Companies
in the Global Medical Care industry.

( Industry Median: 1.26 vs. WOOF: 1.27 )
WOOF' s 10-Year Price/Median PS Value Range
Min: 0.55   Max: 2.73
Current: 1.27

0.55
2.73
Earnings Yield (Greenblatt) 5.40
WOOF's Earnings Yield (Greenblatt) is ranked higher than
77% of the 302 Companies
in the Global Medical Care industry.

( Industry Median: 4.80 vs. WOOF: 5.40 )
WOOF' s 10-Year Earnings Yield (Greenblatt) Range
Min: 3.4   Max: 13.6
Current: 5.4

3.4
13.6
Forward Rate of Return (Yacktman) 3.15
WOOF's Forward Rate of Return (Yacktman) is ranked higher than
65% of the 246 Companies
in the Global Medical Care industry.

( Industry Median: 9.05 vs. WOOF: 3.15 )
WOOF' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -4   Max: 31.7
Current: 3.15

-4
31.7

Business Description

Industry: Health Care Providers » Medical Care
Compare:CHE, FMS, DVA, FSNUY, BDUUF » details
Traded in other countries:VCA.Germany
VCA Inc, formerly known as VCA Antech Inc was formed in 1986 as a Delaware corporation and during the 1990s established a position in the animal hospital and veterinary diagnostic laboratory markets through both internal growth and acquisitions. It is a national animal healthcare company operating in the United States and Canada. It provides veterinary services and diagnostic testing to support veterinary care and sells diagnostic imaging equipment and other medical technology products and related services to the veterinary market. The Company operates in four segments: animal hospitals, veterinary diagnostic laboratories, veterinary medical technology and Vetstreet. The Companys animal hospitals offer a full range of general medical and surgical services for companion animals. Its animal hospitals treat diseases and injuries, provide pharmaceutical products and perform a variety of pet-wellness programs, including health examinations, diagnostic testing, vaccinations, spaying, neutering and dental care. At December 31, 2013, it operated 609 animal hospitals throughout 41 states and 4 Canadian provinces. The Company operates a full-service veterinary diagnostic laboratory network serving all 50 states and certain areas in Canada. Its laboratory network provides sophisticated testing and consulting services used by veterinarians in the detection, diagnosis, evaluation, monitoring, treatment and prevention of diseases and other conditions affecting animals. At December 31, 2013, it operated 56 laboratories of various sizes located strategically throughout the United States and Canada. The Companys Medical Technology business sells digital radiography and ultrasound imaging equipment, provides education and training on the use of that equipment, provides consulting and mobile imaging services, and sells software and ancillary services to the veterinary market. The Company's sales agents market and sell its products and services to veterinary hospitals and universities. It mainly directs its marketing efforts toward its existing clients through customer education efforts. It license its proprietary software, TruDR. TruDR allows for the capture of digital x-ray images and transmits those images to a computer containing archiving and reviewing software. It also provide mobile imaging, consulting, education and training services to its customers. The companion animal healthcare industry is highly competitive and subject to continual change in the manner in which services are delivered and providers are selected. Certain states have laws that prohibit business corporations from providing, or holding themselves out as providers of, veterinary medical care.
» More Articles for WOOF

Headlines

Articles On GuruFocus.com
GuruFocus Real Time Picks of the Week Jun 06 2014 
Morning Coffee: Real-Time Picks May 30 2014 
Building a Technical Swing-Trade with VCA Antech (WOOF) Oct 17 2013 
Arnold Van Den Berg Trims Staples, Sells Out of Dell and Others - Q4 Updates Jan 09 2013 
vet supplies Jul 29 2012 
Weekly Guru Bargains Highlights: WOOF, VPRT, IBN, PHG, CTRP Oct 15 2011 
Arnold Van Den Berg's Top 5 Third-Quarter Buys Oct 11 2011 
arnold Oct 10 2011 
Earning Power: Return on Something Sep 23 2011 
Free Cash Free Calculation for Serial Acquirers: VCA Antech Sep 24 2010 

More From Other Websites
VCA Inc. to Present at 26th Annual Piper Jaffray Healthcare Conference Nov 18 2014
VCA Inc. to Present at 26th Annual Piper Jaffray Healthcare Conference Nov 18 2014
VCA INC Financials Nov 14 2014
10-Q for VCA, Inc. Nov 09 2014
VCA INC Files SEC form 10-Q, Quarterly Report Nov 07 2014
Why VCA (WOOF) Stock Might be a Great Pick Oct 29 2014
VCA Inc. to Present at Stifel Healthcare Conference Oct 28 2014
VCA Inc. to Present at Stifel Healthcare Conference Oct 28 2014
Will VCA (WOOF) Continue to Surge Higher? Oct 27 2014
VCA Inc. to Present at Stephens Fall Investment Conference Oct 24 2014
VCA Inc. to Present at Stephens Fall Investment Conference Oct 24 2014
VCA beats Street 3Q forecasts Oct 23 2014
VCA beats Street 3Q forecasts Oct 23 2014
VCA Inc Earnings Call scheduled for 4:30 pm ET today Oct 23 2014
VCA INC. REPORTS THIRD QUARTER 2014 RESULTS Oct 23 2014
VCA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and... Oct 23 2014
VCA Inc. Reports Third Quarter 2014 Results Oct 23 2014
Cannabis Therapy Gears Up Canna-Pet Business Oct 23 2014
Q3 2014 VCA Inc Earnings Release - 4:00 pm ET Oct 23 2014
Larry Robbins has four big stock ideas Oct 21 2014

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK